Novartis, Others Staring Down Antitrust Lawsuit Over Alleged Exforge Market Fixing
June 29, 2018 A proposed antitrust class action out of New York federal court seeks treble damages stemming from an alleged competition-suppressing scheme by which Novartis monopolized the market for Exforge.